Already a member? Sign in
Fludrocortisone is a synthetic corticosteroid. It is used primarily to replace the missing hormone aldosterone in various forms of adrenal insufficiency such as Addison's disease and congenital adrenal hyperplasia. It is the first line of treatment for orthostatic intolerance.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Orthostatic/Postural Hypotension | 24 | 6 |
|
|
|
|
|
| POTS (Postural Orthostatic Tachycardia Syndrome) | 21 | 7 |
|
|
|
|
|
| Low blood pressure | 16 | 4 |
|
|
|||
| MSA (Multiple System Atrophy) | 13 | 1 |
|
||||
| Addison's Disease | 11 | 2 |
|
|
|||
| Orthostatic Hypotension | 9 | 2 |
|
|
See all 94 patients currently taking Fludrocortisone
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Fludrocortisone
| Weight gain | 2 | |
|---|---|---|
| Dizziness | 1 | |
| Headaches | 1 | |
| Acne breakout | 1 | |
| Skin rash | 1 | |
| Bleeding gums | 1 | |
| See all 10 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Fludrocortisone. See all 12 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 9 | ||
| Doctor's advice | 8 | ||
| Did not seem to work | 4 | ||
| Personal research | 1 | ||
| Other | 1 | ||
| Course of treatment ended | 1 |
Adherence
Taking treatment as prescribed
Adherence of Fludrocortisone
Always |
23 | 92% |
|
|---|---|---|---|
Usually |
0 | 0% |
|
Sometimes |
1 | 4% |
|
Never |
1 | 4% |
|
Burden
Difficulty being on treatment
Burden of Fludrocortisone
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
1 | 4% |
|
A little |
3 | 12% |
|
Not at all |
21 | 84% |
|
Cost
Paid out of pocket
Cost of Fludrocortisone
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
1 | 7% |
|
$50-99 |
0 | 0% |
|
$25-49 |
1 | 7% |
|
< $25 |
12 | 86% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.